The role of epidemiology in challenging the HIV/AIDS pandemic

Journal of Epidemiology

Volumn 11, Issue 2, 2001, Pages 95-102

  Detels, Roger ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37849186059     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.11.95     Document Type: Article

References (15)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) website: http://www.unaids.org/svac/2000/wadOO/riles/wad2000 Master/sld003.htm
2. Detels R, Phair JP, Saah AJ, Rinaldo CR, Munoz A, Kaslow RA, Seminara D, Schrager L, Vermund S. Recent scientific contributions to understanding HIV/AIDS from the Multicenter AIDS Cohort Study. J Epidemiol [Jpn] 1992;2(2):S11-S19.
3. Detels R, English P, Visscher BR, Jacobson L, Kingsley LA, Chmiel JS, Dudley JP, Eldred LJ, Ginzburg HM. Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years. J Acquir Immune Defic Syndr 1989; 2:77-83.
4. Munoz A, Sabin CA, Phillips AN. The incubation period of AIDS. AIDS 1997;ll(SupplA):S69-S76.
5. Detels R, Mann D, Carrington M, Hennessey K, Wu Z, Hiiji KF, Wiley D, Visscher BR, Giorgi JV. Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct. Immunol Lett 1996; 51:29-33.
6. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, Plummer FA. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348: 1347-1351.
7. Munoz A, Kirby AJ, He YD, Margolick J, Visscher BR, Rinaldo CR, Kaslow RA, Phair JP. Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:496-505.
8. Detels R, Fahey JL, Schwanz K, Greene RS, Visscher BR, Gottlieb MS. Relation between sexual practices and T-cell subsets in homosexually active men. Lancet 1983; 1(8325): 609-611.
9. + T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993; 6:904-912.
10. Detels R, Leach CT, Hennessey K, Liu Z, Visscher BR, Cherry JD, Giorgi JV. Persistent cytomegalovirus infection of semen increases risk of AIDS. J Infect Dis 1994; 169: 766-768.
11. + cell levels. The Multicenter AIDS Cohort Study Group. J Infect Dis 1994; 170:775-781.
12. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
13. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862.
14. Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigatovs. JAMA 1998; 280: 1497-1503.
15. Kanshana S, Thewanda D, Teeraratkul A, Limpakamjanarat K, Amornwichet P, Kullerk N, Akksilp S, Sereesittipitak V, Mastro TD, Simonds RJ. Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand. AIDS 2000; 14: 1617-1623.